Effect of topical 0.1% indomethacin solution versus 0.1% fluoromeholon acetate on ocular surface and pain control following laser subepithelial keratomileusis (LASEK)

Cornea

Volumn 23, Issue 6, 2004, Pages 550-553

  Badalà, Federico ^a   Fioretto, Mauro ^a,b,c   Macrì, Angelo ^d,e  

^a UNIVERSITY OF GENOA   (Italy)

^b Ospedale S Spirito Casale Monferrato   (Italy)

^c Microchirurgi Al Eye Clinic   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

^e NONE   (Italy)

Author keywords

Corneal esthesiometry; Fluorometholon acetate; Indomethacin; LASEK; Ocular surface

Indexed keywords

COCODAMOL; FLAREX; FLUORESCEIN; FLUOROMETHOLONE; HY DROP; HYALURONIC ACID; INDOCOLLIRIO; INDOMETACIN; NETILMICIN; TACHIDOL;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FLUORESCENCE; HUMAN; LASER EPITHELIAL KERATOMILEUSIS; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WOUND HEALING;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; EPITHELIUM, CORNEAL; FLUOROMETHOLONE; FLUOROPHOTOMETRY; GLUCOCORTICOIDS; HUMANS; INDOMETHACIN; KERATOMILEUSIS, LASER IN SITU; OPHTHALMIC SOLUTIONS; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; POSTOPERATIVE CARE; WOUND HEALING;

EID: 3342891138     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000121704.40011.3d     Document Type: Article

References (22)

1. Soong HK, Dastjerdi MH. LASEK (laser subepithelial keratomileusis). Curr Opin Ophthalmol. 2002;13:261-263.
2. Gabler B. Winkler von Mohrenfels C, Dreiss AK, et al. Vitality of epithelial cells after alcohol exposure during laser-assisted subepithelial keratectomy flap preparation. J Cataract Refract Surg. 2002;28:1841-1846.
3. Feit R, Taneri S, Azar DT, et al. LASEK results. Ophthalmol Clin North Am. 2003;16:127-135.
4. Chen CC, Chang JH, Lee JB, et al. Human corneal epithelial cell viability and morphology after dilute alcohol exposure. Invest Ophthalmol Vis Sci. 2002;43:2593-2602.
5. Vetrugno M, Quaranta GM, Maino A, et al. A randomized, comparative study of fluorometholone 0.2% and fluorometholone 0.1% acetate after photorefractive keratectomy. Eur J Ophthalmol. 2000;10:39-45.
6. Assouline M, Renard G, Arne JL, et al. A prospective randomised trial of topical solubile 0.1% indomethacin versus 0.1% diclofenac versus placebo for the control of pain following excimer laser photorefractive keratectomy. Ophthalmic Surg Lasers. 1998;29:365-374.
7. Macrí A, Pflugfelder SC. Correlation of Schirmer 1 test and fluorescein clearance tests with the severity of corneal epithelial and eyelid disease. Arch Ophthalmol. 2000;118:1632-1638.
8. Macrí A, Rolando M, Pflugfelder SC. A standardized visual scale for evaluation of tear fluorescein clearance. Ophthalmology. 2000;10:1338-1343.
9. Fantes FE, Hanna KD, Waring GO 3rd, et al. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol. 1990;108:665-675.
10. Vinciguerra P, Camesasca F. Butterfly laser epithelial keratomileusis for myopia. J Refract Surg. 2002;18:S371-S373.
11. Lee JB, Seong GJ, Lee JH, et al. Comparison of laser epithelial keratomileusis and photorefractive keratectomy for low to moderate myopia. J Cataract Refract Surg. 2001;27:565-570.
12. Flach AJ. Cyclo-oxygenase inhibitors in ophthalmology. Surv Ophthalmol. 1992;36:259-284.
13. Phillips AF, Szerenyi K, Campos M, et al. Arachidonic acid metabolites after excimer laser corneal surgery. Arch Ophthalmol. 1993;111:1273-1278.
14. Patrone G. Sacca SC, Macri A, et al. Evaluation of the analgesic effect of 0.1% indomethacin solution on corneal abrasions. Ophthalmologica. 1999;213:350-354.
15. Aras C, Ozdamar A, Aktunc R, et al. The effects of topical steroids on refractive outcome and corneal haze, thickness, and curvature after photorefractive keratectomy with a 6.0-mm ablation diameter. Ophthalmic Surg Lasers. 1998;29:621.
16. Gartry DS, Kerr-Muir MG, Marshall J. The effect of topical corticosteroids on refraction and corneal haze following excimer laser treatment of myopia: An update. A prospective, randomized, double-masked study. Eye. 1993;7:584.
17. O'Brart DP, Lohmann CP, Klonos G, et al. The effects of topical corticosteroids and plasmin inhibitors on refractive outcome, haze, and visual performance after photorefractive keratectomy. A prospective, randomized, observer-masked study. Ophthalmology. 1994;101:1565.
18. Corbett MC, O'Brart DP, Marshall J. Do topical corticosteroids have a role following excimer laser photorefractive keratectomy? J Refract Surg. 1995;11:380.
19. Baek SH, Chang JH, Choi SY, et al. The effect of topical corticosteroids on refractive outcome and corneal haze after photorefractive keratectomy. J Refract Surg. 1997;13:644.
20. Choi SY, Kim HY, Kim JY, et al. Two-year follow-up of eyes without topical corticosteroid treatment after photorefractive keratectomy (PRK). Korean J Ophthalmol. 1998;12:25.
21. Vetrugno M, Maino A, Quaranta GM, et al. The effect of early steroid treatment after PRK on clinical and refractive outcomes. Acta Opthalmol Scand. 2001;79:23-27.
22. Hersh PS, Rice BA, Baer JC, et al. Topical nonsteroidal agents and corneal wound healing. Arch Ophthalmol. 1990;108:577-583.